
Thor Halfdanarson/mayoclinic.org
Feb 20, 2025, 11:21
Thor Halfdanarson: Should Liver resection in patients with high-grade neuroendocrine neoplasms be considered?
Thor Halfdanarson, Medical Oncologist at Mayo Clinic, shared a paper Markus Amman and colleagues on X:
“Liver resection in patients with high-grade neuroendocrine neoplasms, should that be considered…? Pts with G3 NET and NEC certainly have inferior outcomes but some may benefit from surgical debulking. Who are these patients? How can we better select?”
Authors: Markus Amman et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 08:19
Feb 21, 2025, 06:20
Feb 20, 2025, 11:19
Feb 20, 2025, 11:13
Feb 20, 2025, 11:08
Feb 20, 2025, 11:00